Understanding pneumococcal vaccine perceptions in seven countries: Findings from a cross-sectional survey
< .001). Country-level variation was substantial: Brazil and India reported the highest agreement with pneumococcal vaccine safety and efficacy, while France and the UK reported the lowest, despite established health systems. Trust in healthcare providers and public health institutions was the strongest predictor of positive perceptions, while informal sources had little influence. Demographic, socioeconomic, and country-level differences significantly shape pneumococcal vaccine perceptions. Efforts to strengthen trust in healthcare providers, address misinformation among younger adults, and tailor outreach to local contexts are needed to improve uptake globally.
Authors
- Madison M. Fullerton (ORCID: https://orcid.org/0000-0002-8345-2859)
- Donovan Smith (ORCID: https://orcid.org/0000-0001-9632-9326)
- Scott C. Ratzan (ORCID: https://orcid.org/0000-0001-5118-4506)
- Kenneth Rabin
- Jia Hu (ORCID: https://orcid.org/0000-0002-6548-3985)
- Chelsea D’Silva (ORCID: https://orcid.org/0000-0002-8381-4960)
Institutions
- University of Calgary (CA)
- City University of New York (US)
- BC Centre for Disease Control (CA)
- PRA Health Sciences (US)
Publication Details
- Journal
- Human Vaccines & Immunotherapeutics
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1080/21645515.2026.2650844
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Merck Canada